Brain-Computer Interface (BCI) technology has made significant strides in medical applications in recent years—enabling paralyzed patients to control robotic arms, partially restore motor functions, and even type using thought alone. However, widespread clinical adoption still faces multiple hurdles. Most current BCI systems rely on invasive electrodes, which carry surgical risks and long-term stability issues; non-invasive alternatives are safer but suffer from limited signal accuracy and slower response times. Additionally, high inter-individual variability necessitates extensive personalization and training, hindering broad usability. Data privacy concerns, ethical guidelines, and regulatory approval processes also remain underdeveloped. Although companies like Neuralink have begun human trials, a safe, reliable, and widely accessible medical-grade BCI is likely still 5 to 10 years—or more—away from routine clinical use. Thus, while the potential is immense, mainstream medical application remains a considerable distance off.
脑机接口（Brain-Computer Interface, BCI）技术近年来在医疗领域取得显著进展，例如帮助瘫痪患者控制机械臂、恢复部分运动功能，甚至实现意念打字。然而，要实现大规模临床应用，仍面临多重挑战。首先，当前多数BCI系统依赖侵入式电极，存在手术风险和长期稳定性问题；非侵入式设备虽安全性高，但信号精度和响应速度有限。其次，个体差异大，需高度个性化的校准与训练，限制了通用性。此外，数据隐私、伦理规范及监管审批流程也尚未完善。尽管Neuralink等公司已开展人体试验，但真正安全、可靠、可普及的医疗级脑机接口，预计还需5至10年甚至更长时间的研发与验证。因此，虽然前景广阔，但距离正式临床广泛应用仍有不小距离。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/15174.html